---
title: "Silktex Ltd (526835) — Share Price, Financials & Analysis"
symbol: "526835"
company: "Silktex Ltd"
canonical: "https://tapetide.com/stocks/526835"
isin: "INE056B01012"
bse_code: "526835"
generated_at: "2026-10-13T11:00:45.528Z"
---

# Silktex Ltd (526835)

Canonical page: https://tapetide.com/stocks/526835

## Company

- **BSE Code:** 526835
- **ISIN:** INE056B01012
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** silktexlimited.com

## About

The Company is primarily engaged in manufacturing of Natural silk fabrics / Silk blended fabrics and to a limited extent in trading of silk fabrics.

## Latest Price

## Key Insights

### Strengths

- Stock is trading at 0.15 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -11.2% over past five years.
- Company has a low return on equity of -5.17% over last 3 years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 41% | — | — |
| revenue growth | 66% | -15% | -11% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.09 | 0.88 | 1.35 | 0.96 | 1.79 | 0.82 | 1.71 | 1.11 |
| Expenses | 2.53 | 1.23 | 2.02 | 2.49 | 1.73 | 1.23 | 1.8 | 2.63 |
| Operating Profit | -2.44 | -0.35 | -0.67 | -1.53 | 0.06 | -0.41 | -0.09 | -1.52 |
| OPM % | -2711.11 | -39.77 | -49.63 | -159.38 | 3.35 | -50 | -5.26 | -136.94 |
| Other Income | 0 | 0 | 0 | 0.56 | 0 | 0 | 0.58 | 1.42 |
| Interest | 0.47 | 0.09 | 0.7 | 0.47 | 0.37 | 0.31 | 0.42 | 0.61 |
| Depreciation | 0.33 | 0.33 | 0.33 | 0.33 | 0.76 | 0.43 | 0.38 | 0.31 |
| Profit before tax | -3.24 | -0.77 | -1.7 | -1.77 | -1.07 | -1.15 | -0.31 | -1.02 |
| Tax % | -2.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -3.16 | -0.76 | -1.7 | -1.77 | -1.08 | -1.15 | -0.31 | -1.02 |
| EPS in Rs | -4.16 | -1 | -2.24 | -2.33 | -1.42 | -1.51 | -0.41 | -1.34 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 29.71 | 32.23 | 26.72 | 29.84 | 20.3 | 16.41 | 5.43 |
| Expenses | 21.51 | 23.28 | 20.6 | 24.81 | 17.44 | 17.56 | 7.39 |
| Operating Profit | 8.2 | 8.95 | 6.12 | 5.03 | 2.86 | -1.15 | -1.96 |
| OPM % | 27.6 | 27.77 | 22.9 | 16.86 | 14.09 | -7.01 | -36.1 |
| Other Income | 0.04 | 0.09 | 0.79 | -0.05 | 0.17 | 0.1 | 2 |
| Interest | 1.06 | 1.23 | 1.34 | 1.6 | 1.12 | 1.28 | 1.71 |
| Depreciation | 3.16 | 3.66 | 4.1 | 3.09 | 2.45 | 2.46 | 1.88 |
| Profit before tax | 4.02 | 4.15 | 1.47 | 0.29 | -0.54 | -4.79 | -3.55 |
| Tax % | -0.75 | 10.6 | 93.88 | 265.52 | -9.26 | -37.58 | — |
| Net Profit | 4.05 | 3.71 | 0.09 | -0.48 | -0.49 | -2.99 | -3.56 |
| EPS in Rs | 5.33 | 4.88 | 0.12 | -0.63 | -0.64 | -3.93 | -4.68 |
| Dividend Payout % | 28.15 | 30.73 | 633.33 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 |
| Reserves | 17.34 | 19.72 | 19.14 | 18.66 | 18.17 | 15.18 |
| Borrowings | 15.6 | 17.03 | 18.04 | 18.72 | 15.83 | 15.51 |
| Other Liabilities | 4.54 | 4.52 | 5.73 | 5.67 | 5.09 | 5.28 |
| Total Liabilities | 45.08 | 48.87 | 50.51 | 50.65 | 46.69 | 43.57 |
| Fixed Assets | 19.66 | 22.3 | 25.62 | 23.48 | 21.38 | 18.83 |
| CWIP | 4.48 | 0.61 | 0.35 | 0.05 | 0.2 | 0.64 |
| Investments | 0 | 0 | 0.1 | 0.1 | 0.09 | 0 |
| Other Assets | 20.94 | 25.96 | 24.44 | 27.02 | 25.02 | 24.1 |
| Total Assets | 45.08 | 48.87 | 50.51 | 50.65 | 46.69 | 43.57 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 4.01 | 3.27 | 7.39 | 2.37 | 4.38 | 1.69 |
| Cash from Investing Activity | -8.01 | -2.82 | -6.88 | -1.03 | -0.37 | -0.37 |
| Cash from Financing Activity | 3.63 | -0.87 | -0.61 | -1.26 | -3.81 | -1.37 |
| Net Cash Flow | -0.37 | -0.42 | -0.1 | 0.08 | 0.2 | -0.05 |
| Free Cash Flow | -4.04 | 0.43 | 0.55 | 1.14 | 4 | 1.12 |
| CFO/OP | 51 | 41 | 125 | 55 | 164 | -147 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 62.41 | 63.65 | 58.6 | 55.41 | 67.97 | 75.18 |
| Inventory Days | 390.23 | 506.32 | 591.15 | 519.56 | 705.7 | 760.19 |
| Days Payable | 41.94 | 54.56 | 82.83 | 88.32 | 119.52 | 218.89 |
| Cash Conversion Cycle | 410.71 | 515.41 | 566.92 | 486.65 | 654.15 | 616.48 |
| Working Capital Days | 208.12 | 250.85 | 275.25 | 282.43 | 384.78 | 412.6 |
| ROCE % | — | 12.7 | 6.37 | 4.32 | 1.34 | -8.64 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Dec 2017 |
| --- | --- | --- |
| Promoters | 30.98% | 30.98% |
| DIIs | 0.84% | 0.84% |
| Public | 68.19% | 68.19% |
| No. of Shareholders | 13571 | 13570 |

### Quarterly

| Category | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 37.89% | 37.89% | 37.89% | 30.98% | 30.98% | 30.98% | 30.98% |
| FIIs | 0.84% | 0.84% | 0.84% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0.84% | 0.84% | 0.84% | 0.84% |
| Public | 61.28% | 61.28% | 61.28% | 68.19% | 68.19% | 68.19% | 68.19% |
| No. of Shareholders | 13457 | 13571 | 13571 | 13571 | 13570 | 13570 | 13570 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 5 / 5 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 38.84 | Buy |
| EMA (10) | 38.95 | Buy |
| SMA (20) | 39.54 | Buy |
| EMA (20) | 39.32 | Buy |
| SMA (50) | 40.41 | Sell |
| EMA (50) | 40.04 | Sell |
| SMA (100) | 40.49 | Sell |
| EMA (100) | 41.05 | Sell |
| SMA (200) | 42.09 | Sell |
| EMA (200) | 44.41 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 52.14 | Neutral |
| MACD (12,26,9) | -0.5 | Buy |
| Stochastic (14,3,3) | 57.36 | Neutral |
| ADX (14) | 22.84 | Neutral |
| Williams %R (14) | -18.26 | Sell |
| ATR (14) | 1.96 | High Volatility |
| ROC (12) | -0.94 | Sell |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 58.32 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2016-05-30 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5FF6D2E3_AEEF_4682_B128_8578B0DC1887_114259.pdf) |
| 2016-05-30 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/5/5FF6D2E3_AEEF_4682_B128_8578B0DC1887_114259.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2016 | [Financial Year 2016](https://www.bseindia.com/bseplus/AnnualReport//5900940316.pdf) |
| 2015 | [Financial Year 2015](https://www.bseindia.com/bseplus/AnnualReport//5900940315.pdf) |
| 2014 | [Financial Year 2014](https://www.bseindia.com/bseplus/AnnualReport//5900940314.pdf) |
| 2013 | [Financial Year 2013](https://archives.nseindia.com/annual_reports/AR_910_FARMAXIND_2012_2013_20092013150945.zip) |
| 2013 | [Financial Year 2013](https://www.bseindia.com/bseplus/AnnualReport//5900940313.pdf) |
| 2012 | [Financial Year 2012](https://www.bseindia.com/bseplus/AnnualReport//5900940312.pdf) |
| Mar 2011 | [Annual Report 2011](https://www.bseindia.com/bseplus/AnnualReport/526835/5268350311.pdf) |
| 2011 | [Financial Year 2011](https://www.bseindia.com/bseplus/AnnualReport//5900940311.pdf) |
| 2010 | [Financial Year 2010](https://www.bseindia.com/bseplus/AnnualReport//5900940310.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:00:45.528Z.